Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood is having another rough year. The largest of the Ark Invest exchange-traded funds is down 14% this year in an otherwise buoyant year for growth investors. The fund is down 72% since peaking in early 2021. As the founder, CEO, and primary stock picker, she is tasked to get Ark back on track. And she's not backing down.
Wood is making moves, and Ark publishes its transactions at the end of every trading day. What is Wood buying now? She added to existing stakes in Guardant Health (NASDAQ: GH), (NYSE: OKLO), and CRISPR Technologies (NASDAQ: CRSP) on Tuesday. Why are these attractive stocks to consider buying right now? Let's take a closer look at Wood's three latest buys.
Guardant Health isn't dragging down Ark's performance this year. The developer of oncological tests is up 34% this year, beating the market averages. The shares have actually more than doubled since bottoming out in April.
Source Fool.com
